The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBTG Share News (BTG)

  • There is currently no data for BTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interventional medicine revenue surges at BTG

Tue, 15th Nov 2016 07:41

(ShareCast News) - Specialist healthcare company BTG posted its interim results for the six months to 30 September on Tuesday, with double-digit revenue growth underpinned by 24% constant exchange rate growth in interventional medicine revenues.The FTSE 250 firm said its operating profit for the period reflected planned investments, and claimed its adjusted and IFRS earnings were impacted by one-time costs.On the financial summary, the 24% revenue growth saw the total leap to £285.4m year-on-year, with interventional medicine revenue up 39% overall to £98.1m.Its adjusted operating profit was up 25% to £78.8m, though IFRS operating profit dropped 34% over the same time last year to £29.1m.Adjusted basic earnings per share were 13.9p - down 5% - while IFRS basic earnings per share were down 75% to 3.4p.The company reported free cash flow for the half year of £55.7m, down 7%, with net cash flow from operating activities down 3% to £60.8m."The business has performed well during the first half, and the outlook for the full year is strong," said CEO Louise Makin."We have the capabilities and financial strength to take advantage of the increasing opportunities we are seeing to expand our Interventional Medicine business."By accelerating our growth strategy through reinvestment of our cash flows to maximise the value of and expand the current portfolio, we can build leadership positions in selected areas of interventional medicine and thereby create sustainable value for shareholders."
More News
15 Dec 2015 13:58

BTG rallies as RBC hails long-term growth prospects

(ShareCast News) - RBC Capital Markets initiated coverage of specialist pharmaceutical company BTG at 'outperform' with a price target of 820p, saying it should be a long-term holding. It said the shares have underperformed materially over the past year and, while medium-term market expectations are

Read more
15 Dec 2015 09:46

BROKER RATINGS SUMMARY: Berenberg Upgrades Meggitt To Buy From Hold

Read more
14 Dec 2015 09:33

BROKER RATINGS SUMMARY: Goldman Sachs Upgrades Fresnillo To Buy

Read more
14 Dec 2015 08:38

LONDON MARKET OPEN: BG And Shell Rise On Chinese Regulator Approval

Read more
14 Dec 2015 08:14

BTG wins US approval for BC Bead Lumi

(ShareCast News) - Specialist pharmaceutical firm BTG said it had won US regulatory approval for its LC Bead Lumi radiation treatment. The company added that a trial of its PneumRx endobronchial coil implant for severe emphysema had produced positive results with all primary and secondary endpoints

Read more
14 Dec 2015 07:45

BTG Gets Positive PneumRx Study Results, LC Bead LUMI Clearance

Read more
11 Dec 2015 18:10

BTG Says WellStat Therapeutics' Vistogard Approved In US

Read more
13 Nov 2015 09:49

BROKER RATINGS SUMMARY: Davy Expects Lloyds To Outperform

Read more
11 Nov 2015 09:32

BROKER RATINGS SUMMARY: JPMorgan And S&P Capital IQ Positive On ITV

Read more
10 Nov 2015 10:28

WINNERS & LOSERS SUMMARY: Experian And Vodafone Lead Blue-Chip Risers

Read more
10 Nov 2015 08:03

BTG's interim profit soars thanks to solid growth across the board

(ShareCast News) - Healthcare group BTG has posted an increase in interim pre-tax profit, boosted by solid growth across all of its divisions. In the six months to 30 September, the FTSE 250 group posted a 40.6% year-on-year increase in pre-tax profit to £52.9m, while revenue rose 20% to £229.6m. T

Read more
10 Nov 2015 07:51

BTG First Half Profit Rises As All Segments Experience Revenue Rise

Read more
3 Nov 2015 16:35

Earnings, Trading Statements Calendar - Week Ahead

Read more
28 Oct 2015 13:50

FTSE 250 movers: Just Retirement boosted by CMA merger clearance

(ShareCast News) - After an initial stumble, the FTSE 250 fought its way back into positive territory over the day, By 1420 GMT, the UK mid-cap index was up 0.28% at just over 17,000 points, but not rising as fast as its blue chip sister index 0.85% gain. Pharmaceutical group BTG was given a shot i

Read more
7 Oct 2015 13:46

FTSE 250 movers: Miners and energy stocks rally; Wizz Air crashes

(ShareCast News) - London's FTSE 250 index was down 0.2% at 17,101.89 just after 1400 BST, underperforming the broader market. Miners were firmly on the front foot as metals prices advanced and the sector got a boost from an upbeat note by Morgan Stanley. The bank upgraded its stance on the European

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.